“…Advances in recent research have demonstrated that liposomes and cyclodextrins can be used for the delivery of CPT to reduce its toxicity and promote its properties. [15][16][17][18][19][20][21][22][23] However, most of these carriers do not meet the requirements of a high drug-delivery efficiency, ease of dispersion, and controlled particle size, which are key to clinical translation. 24,25 Calixarene (CA), a crucial component of supramolecular families, is a supramolecular macrocyclic compound made of phenol units connected by methylene bridges, with an easy chemical modification of the upper and lower edges of the phenol units, an adjustable size, and conformation of the hydrophobic cavities in the structure.…”